● Covered by 1 source · 1 reportMedium impact1 negative
UK Health Minister Expresses Concern Over Palantir's NHS Role Amidst Patient Data Opt-Outs
Key points
- Health Minister Frith expressed concern over public mistrust of Palantir.
- 60,000 more patients opted out of data sharing between mid-May and mid-July.
- The government is reviewing Palantir's £330m NHS data platform contract.
- Palantir's previous government contracts have faced controversy.
Minister Raises Concerns Over Palantir's NHS Involvement
James Frith, the UK's health innovation minister, has publicly stated his worry regarding "mistrust" of Palantir, a US defense and health tech company. This concern is linked to the potential impact on public willingness to share data with the NHS for research purposes. The government is currently evaluating Palantir's £330 million contract to manage the health service's federated data platform, which aims to improve efficiency and patient outcomes.
Increase in Patient Data Opt-Outs
Frith's comments follow a notable increase in patients opting out of sharing their medical data. Between mid-May and mid-July, an additional 60,000 individuals withdrew their private information using the national data opt-out mechanism. Frith acknowledged this rise, noting it aligns with media attention surrounding Palantir's role within the NHS.
Controversies and Contract Review
Doctors and patient advocacy groups are urging the Labour party to activate a break clause in Palantir's seven-year contract. These groups cite Palantir's past work with the Israeli military and Donald Trump's ICE immigration agency, and question the value for money provided by the company. Palantir's government contracts have previously been controversial, including an instance where ministers apologized after it was revealed company staff had access to identifiable patient data. London's mayor, Sadiq Khan, also blocked a £50 million contract for Palantir with the Metropolitan police, leading to a lawsuit from the company.
Palantir's Defense and NHS Data
Palantir and its supporters assert that its AI-driven technology has contributed to reducing NHS waiting lists for surgery. A company spokesperson claimed their technology has helped trusts record 110,000 additional operations, a 15% reduction in discharge delays for long-stay patients, and a 6.8% improvement in cancer diagnosis within 28 days. While NHS England has reported similar figures, it has stated it cannot establish a direct cause-and-effect relationship, and the government's statistics watchdog is investigating the data.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
Reporting from
UK Health Innovation Minister James Frith voiced concerns about public "mistrust" of Palantir, citing a rise in patients withdrawing their data from NHS research. This comes as the government reviews Palantir's £330 million contract for the NHS federated data platform, with critics highlighting the company's controversial past contracts.